Vtv Therapeutics Inc (VTVT)

Nov 19, 2024

Insider Buying: Paul Sekhri Acquires Shares of vTv Therapeutics Inc (VTVT) - GuruFocus.com

Nov 19, 2024

Nov 19, 2024

vTv therapeutics CEO Paul Sekhri buys $83,811 in stock - Investing.com

Nov 19, 2024

Nov 17, 2024

vTv Therapeutics (NASDAQ:VTVT) shareholders are up 29% this past week, but still in the red over the last five years - Simply Wall St

Nov 17, 2024

Nov 17, 2024

vTv Therapeutics (NASDAQ:VTVT) adds US$9.5m to market cap in the past 7 days, though investors from five years ago are still down 71% - Yahoo Finance

Nov 17, 2024

Nov 16, 2024

Objective long/short (VTVT) Report - Stock Traders Daily

Nov 16, 2024

Nov 13, 2024

vTv Therapeutics (FRA:5VT0) 5-Year EBITDA Growth Rate : 25.50% (As of Jun. 2024) - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

VTv Therapeutics: Q3 Earnings Snapshot - Darien Times

Nov 13, 2024

Nov 12, 2024

vTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update - GlobeNewswire

Nov 12, 2024

Nov 06, 2024

(VTVT) Investment Analysis - Stock Traders Daily

Nov 06, 2024

Oct 26, 2024

vTv Therapeutics Faces License Agreement Termination - Yahoo Finance

Oct 26, 2024

Oct 26, 2024

How the (VTVT) price action is used to our Advantage - Stock Traders Daily

Oct 26, 2024

Oct 25, 2024

VTv, OnKure Terminate Cellular Drug Licensing Agreement - MarketWatch

Oct 25, 2024

Oct 25, 2024

vTv Therapeutics ends key license agreement with OnKure - Investing.com

Oct 25, 2024

Oct 25, 2024

VTv Therapeutics : Termination of Material Agreement Form 8 K - Marketscreener.com

Oct 25, 2024

Oct 21, 2024

VTv Therapeutics: Q2 Earnings Snapshot - Barchart

Oct 21, 2024

Oct 21, 2024

Alzheimer's disease Market Size in the 7MM was ~USD 3,500 Million in 2022 | DelveInsight - openPR

Oct 21, 2024

Oct 15, 2024

Trading (VTVT) With Integrated Risk Controls - Stock Traders Daily

Oct 15, 2024

Oct 03, 2024

Alzheimer’s disease Treatment Market Size in the 7MM was ~USD 3,500 Million in 2022, estimated DelveInsight - Barchart

Oct 03, 2024

Oct 01, 2024

Alzheimer’s Disease Treatment Market Trends As Discussed In New Market Research Report - WhaTech

Oct 01, 2024

Sep 27, 2024

vTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024

Sep 18, 2024

Views of Wall Street’s Leading Experts on Volcon Inc - SETE News

Sep 18, 2024

Sep 18, 2024

Travere Therapeutics Inc (TVTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Sep 18, 2024

Sep 18, 2024

Valvoline Inc [VVV] Insider Activity: An Update for Investors - Knox Daily

Sep 18, 2024

Sep 18, 2024

Ventyx Biosciences Inc (VTYX) looking to reclaim success with recent performance - SETE News

Sep 18, 2024

Sep 17, 2024

What is going on with VCHA? Cancellations, member hiatus and more - MSN

Sep 17, 2024

Sep 17, 2024

Vital Energy Inc. (VTLE)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Sep 17, 2024

Sep 17, 2024

Vanguard Total Corporate Bond Fund (NASDAQ:VTC) Reaches New 52-Week High at $79.92 - MarketBeat

Sep 17, 2024

Sep 17, 2024

VTYX overperforms with a 2.18 increase in share price - US Post News

Sep 17, 2024

Sep 17, 2024

VTLE’s latest rating updates from top analysts. - Knox Daily

Sep 17, 2024

Sep 17, 2024

TV’s 2023 Market Dance: Down -32.71% – Time to Invest? - The InvestChronicle

Sep 17, 2024

Sep 15, 2024

Texas Permanent School Fund Corp Sells 9,072 Shares of Veralto Co. (NYSE:VLTO) - Defense World

Sep 15, 2024

Sep 13, 2024

Learn to Evaluate (VTVT) using the Charts - Stock Traders Daily

Sep 13, 2024

Sep 13, 2024

Travere Therapeutics Inc [TVTX] Shares Rise 2.94 % on Thursday - Knox Daily

Sep 13, 2024

Sep 12, 2024

Neighbors concerned with proposed hospital in Webster Groves - KTVI Fox 2 St. Louis

Sep 12, 2024

Aug 28, 2024

When (VTVT) Moves Investors should Listen - Stock Traders Daily

Aug 28, 2024

Aug 24, 2024

Here's Why We're Watching vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Situation - Simply Wall St

Aug 24, 2024

Aug 16, 2024

We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate - Yahoo Finance

Aug 16, 2024

Aug 16, 2024

Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Rises By 45.9% - Defense World

Aug 16, 2024

Aug 16, 2024

VTVT (vTv Therapeutics) Operating Cash Flow per Share : $-6.50 (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Aug 16, 2024

VTVT (vTv Therapeutics) Free Cash Flow : $-21.81 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Aug 16, 2024

VTVT (vTv Therapeutics) Change In Receivables : $-0.20 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Aug 16, 2024

VTVT (vTv Therapeutics) Cyclically Adjusted Book per Share : $-228.01 (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Aug 16, 2024

VTVT (vTv Therapeutics) Short-Term Capital Lease Obligation : $0.18 Mil (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Aug 15, 2024

VTVT (vTv Therapeutics) Revenue per Share : $0.24 (TTM As of Jun. 2024) - GuruFocus.com

Aug 15, 2024

Aug 15, 2024

VTVT (vTv Therapeutics) Ending Cash Position : $45.53 Mil (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024

Aug 15, 2024

VTVT (vTv Therapeutics) Net Income From Continuing Operatio - GuruFocus.com

Aug 15, 2024

Aug 15, 2024

VTVT (vTv Therapeutics) Cash from Discontinued Operating Ac - GuruFocus.com

Aug 15, 2024

Aug 15, 2024

VTVT (vTv Therapeutics) GF Value Rank : 1 (As of Aug. 15, 2024) - GuruFocus.com

Aug 15, 2024

Aug 15, 2024

VTVT (vTv Therapeutics) Capex-to-Operating-Cash-Flow : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024

Aug 15, 2024

VTVT (vTv Therapeutics) Liabilities-to-Assets : 0.56 (As of Jun. 2024) - GuruFocus.com

Aug 15, 2024